AzTrials
AzTrials

Lumbosacral AnomaliesLSTVNCT06566846

Lumbosacral Transitional Vertebra Prevalence Among Egypt Population and Its Association With Lumbar Degeneration

An observational study of Lumbosacral Anomalies, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

retrospective cross sectional study Study Setting: Cases will be recruited from the recorded data system at the department of diagnostic radiology, Assiut University. Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Lumbosacral Anomalies
How many people
500 participants
Where
No sites listed yet
Study dates
1 Sep 2024to Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The study will include all patients underwent KUB CT in Assuit university hospital at one year.

Who may be able to join

  • • All MSCT KUB studies from 2022 till 2023
  • age between 20-50

Who cannot join

  • All cases below 20 and above 50 .
  • previous history of lumbar spine surgery;
  • non-degenerative pathologies in the lumbar spine which could interrupt the evaluation of lumbar spine degeneration, including spinal tumors, infections, and traumatic fractures;
  • images with poor quality

About this study

Official title: Lumbosacral Transitional Vertebra(LSTV ) Prevalence in Egypt Population and Its Association With Lumbar Degeneration :Retrospective Evaluation of Consecutive Abdominal CT Scans

retrospective cross sectional study Study Setting: Cases will be recruited from the recorded data system at the department of diagnostic radiology, Assiut University.

Read the detailed description
  • Study subjects:
  1. Inclusion criteria:
  • All patients underwent MSCT KUB from 2022 till 2023
  • Age between 20-50 years old
  1. Exclusion criteria:
  • All cases below 20 and above 50 .
  • previous history of lumbar spine surgery;
  • non-degenerative pathologies in the lumbar spine which could interrupt the evaluation of lumbar spine degeneration, including spinal tumors, infections, and traumatic fractures;
  • images with poor quality
  1. Sample Size Calculation: The study will include all patients underwent KUB CT in Assuit university hospital. Objective of this research study will be accomplished through the following consecutive steps:
  • Patient Enrolment and sample collection:

Sample are patients underwent MSCT KUB at our hospital , ASSUIT university at one year. Lumbosacral spine will be assessed for LSTV ,the patient images will be divided into two groups ,one which has LSTV as cases and other group with normal spine as control. both groups will be assessed for associated disc degeneration ,facet arthropathy sacroiliac joint degeneration ,paravertebral muscle volume and will be compared with control.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06566846
Study groupRoleWhat they receive
LSTV group and control groupNot described
1 and 21. for cases with LSTV 2. for normal studies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. prevalence

    prevalence of LSTV among egyptians

    Measured: one year

Secondary outcomes (4)
  1. correlation of LSTV with lumbar disc degeneration

    association between LSTV and disc height ,segmental disc wedge angle and degree of disc prolapse(mild ,moderate ,severe)

    Measured: one year

  2. correlation of LSTV with facet joint arthropathy

    fact joint arthropathy will be assessed as unilateral ,bilateral and its degree(mild ,moderate ,severe)

    Measured: one year

  3. correlation of LSTV with sacroiliac degeneration

    sacroiliac joint will be assessed as unilateral ,bilateral and degree (mild ,moderate ,severe)

    Measured: one year

  4. correlation of LSTV with paravertebral muscle volume

    bilateral psoas muscle volume in cubic centimeter

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2024
  2. Study start1 Sep 2024 (estimated)
  3. Primary completionSep 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06566846
Sponsor's protocol ID
AssuitU12345
Acronym
LSTV
Status last verified
Aug 2024
First submitted
7 Aug 2024
Last updated
22 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbosacral Anomalies, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

prevalence (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in